DENVER, March 7, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCMKTS: MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced that the Company will be presenting at the second annual LD Micro Virtual Conference on Tuesday, March 12, 2019 at 11:40AM ET.
Andy Williams, Co-Founder and CEO of Medicine Man Technologies, will be giving the presentation and answering questions from investors. To access Medicine Man Technologies live webcast of the presentation please use the following link:
"We are excited to be presenting at LD Micro during such an important time as we complete our transition to an international cannabis operator with existing relationships in 18 states and seven countries," says Andy Williams, Co-Founder and CEO of Medicine Man Technologies. "We will present the details behind our pending acquisitions of MedPharm Holdings, LLC and Medicine Man Denver. Both acquisitions are anticipated to close later this year and will give Medicine Man Technologies the only federal research license for cannabis while bringing the company to a combined annual revenue run rate of over $40 million. This will position the company to drive revenue through traditional partnerships only reserved for pharmaceutical companies while further establishing our brand and increasing revenue growth in our four retail locations across Colorado."
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com for more information.
About Medicine Man Technologies
Medicine Man Technologies is a fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products, and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation, and distribution operations. The Company's client portfolio includes active and past clients in 18 states and seven countries.
Forward-looking Statements
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
CONTACT: Investor Relations Contact: [email protected], 1-866-348-1997
SOURCE Medicine Man Technologies Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article